Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1984-04-20
1987-06-30
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 935107, A61K 4300, A61K 4900
Patent
active
046769730
ABSTRACT:
Epithelial lung tumors are known to produce specific biological substances such as hormones. Radiolabelled antibodies to such substances are prepared and ventilated by a subject. Deposition of the radiolabelled antibodies occurs in the respiratory air passages and with controlled particle size and inhalation particularly in the tracheo-bronchial tree.
The antibodies react antigenically with the biological substances, becoming localized at the tumor sites. Concentrations of radiolabelled antibodies may be detected using ratio detection means such as a gamma camera.
REFERENCES:
patent: 4280991 (1981-07-01), Burch
patent: 4444744 (1984-04-01), Goldenberg
patent: 4514506 (1985-04-01), Braatz et al.
Best et al., "Clinical Nuclear Medicine", vol. 10, No. 4, Apr. 1985, p. 297.
Best et al., "Journal of Nuclear Medicine", 25, p. 18 (1984).
Scott, Diss. Abst. Int. B, 44(4) 1983, p. 1054.
Tzeng, Diss. Abst. Int. B, 44(4) 1983, p. 1068.
Radcliffe, from Markers for Diagnosis and Monitoring of Human Cancer, Serono Symposia, vol. 46, Colnaghi et al., Eds., Academic Press, Ing, London, 1982, pp. 85-94.
LandOfFree
Method for diagnosing lung abnormalities using radiolabelled age does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosing lung abnormalities using radiolabelled age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing lung abnormalities using radiolabelled age will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-446898